155 related articles for article (PubMed ID: 37863321)
1. Analysis of blood and nasal epithelial transcriptomes to identify mechanisms associated with control of SARS-CoV-2 viral load in the upper respiratory tract.
Moradi Marjaneh M; Challenger JD; Salas A; Gómez-Carballa A; Sivananthan A; Rivero-Calle I; Barbeito-Castiñeiras G; Foo CY; Wu Y; Liew F; Jackson HR; Habgood-Coote D; D'Souza G; Nichols SJ; Wright VJ; Levin M; Kaforou M; Thwaites RS; Okell LC; Martinón-Torres F; Cunnington AJ; ;
J Infect; 2023 Dec; 87(6):538-550. PubMed ID: 37863321
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study.
Fox-Lewis A; Fox-Lewis S; Beaumont J; Drinković D; Harrower J; Howe K; Jackson C; Rahnama F; Shilton B; Qiao H; Smith KK; Morpeth SC; Taylor S; Blakiston M; Roberts S; McAuliffe G
Pathology; 2021 Jun; 53(4):530-535. PubMed ID: 33838922
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Viral Load Cycle Threshold Values in Patients with SARS-CoV-2 Associated Pneumonia with Real-Time PCR Method.
Bakir A; Hosbul T; Cuce F; Artuk C; Taskin G; Caglayan M; Guney M; Kurkcu MF; Yildiz F; Erdal H; Erdem G
J Infect Dev Ctries; 2021 Oct; 15(10):1408-1414. PubMed ID: 34780363
[TBL] [Abstract][Full Text] [Related]
5. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
[TBL] [Abstract][Full Text] [Related]
6. Modelling upper respiratory viral load dynamics of SARS-CoV-2.
Challenger JD; Foo CY; Wu Y; Yan AWC; Marjaneh MM; Liew F; Thwaites RS; Okell LC; Cunnington AJ
BMC Med; 2022 Jan; 20(1):25. PubMed ID: 35022051
[TBL] [Abstract][Full Text] [Related]
7. Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection.
Maltezou HC; Raftopoulos V; Vorou R; Papadima K; Mellou K; Spanakis N; Kossyvakis A; Gioula G; Exindari M; Froukala E; Martinez-Gonzalez B; Panayiotakopoulos G; Papa A; Mentis A; Tsakris A
J Infect Dis; 2021 Apr; 223(7):1132-1138. PubMed ID: 33388780
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19.
Chen PZ; Bobrovitz N; Premji ZA; Koopmans M; Fisman DN; Gu FX
Elife; 2021 Aug; 10():. PubMed ID: 34414888
[TBL] [Abstract][Full Text] [Related]
9. Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19.
Burrel S; Hausfater P; Dres M; Pourcher V; Luyt CE; Teyssou E; Soulié C; Calvez V; Marcelin AG; Boutolleau D
Int J Infect Dis; 2021 Jan; 102():10-13. PubMed ID: 33115679
[TBL] [Abstract][Full Text] [Related]
10. Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis.
Weiss A; Jellingsø M; Sommer MOA
EBioMedicine; 2020 Aug; 58():102916. PubMed ID: 32711256
[TBL] [Abstract][Full Text] [Related]
11. In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age.
Lieberman NAP; Peddu V; Xie H; Shrestha L; Huang ML; Mears MC; Cajimat MN; Bente DA; Shi PY; Bovier F; Roychoudhury P; Jerome KR; Moscona A; Porotto M; Greninger AL
PLoS Biol; 2020 Sep; 18(9):e3000849. PubMed ID: 32898168
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study.
Derqui N; Koycheva A; Zhou J; Pillay TD; Crone MA; Hakki S; Fenn J; Kundu R; Varro R; Conibear E; Madon KJ; Barnett JL; Houston H; Singanayagam A; Narean JS; Tolosa-Wright MR; Mosscrop L; Rosadas C; Watber P; Anderson C; Parker E; Freemont PS; Ferguson NM; Zambon M; McClure MO; Tedder R; Barclay WS; Dunning J; Taylor GP; Lalvani A;
Lancet Microbe; 2023 Jun; 4(6):e397-e408. PubMed ID: 37031689
[TBL] [Abstract][Full Text] [Related]
13. Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults.
Costa R; Bueno F; Albert E; Torres I; Carbonell-Sahuquillo S; Barrés-Fernández A; Sánchez D; Padrón C; Colomina J; Lázaro Carreño MI; Bretón-Martínez JR; Martínez-Costa C; Navarro D
Clin Microbiol Infect; 2021 Dec; 27(12):1858.e1-1858.e7. PubMed ID: 34384874
[TBL] [Abstract][Full Text] [Related]
14. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model.
Proud PC; Tsitoura D; Watson RJ; Chua BY; Aram MJ; Bewley KR; Cavell BE; Cobb R; Dowall S; Fotheringham SA; Ho CMK; Lucas V; Ngabo D; Rayner E; Ryan KA; Slack GS; Thomas S; Wand NI; Yeates P; Demaison C; Zeng W; Holmes I; Jackson DC; Bartlett NW; Mercuri F; Carroll MW
EBioMedicine; 2021 Jan; 63():103153. PubMed ID: 33279857
[TBL] [Abstract][Full Text] [Related]
16. Innate and Adaptive Immune Responses in the Upper Respiratory Tract and the Infectivity of SARS-CoV-2.
Ramasamy R
Viruses; 2022 Apr; 14(5):. PubMed ID: 35632675
[TBL] [Abstract][Full Text] [Related]
17. The Upper Respiratory Tract Microbiome Network Impacted by SARS-CoV-2.
Li W; Ma ZS
Microb Ecol; 2023 Aug; 86(2):1428-1437. PubMed ID: 36509943
[TBL] [Abstract][Full Text] [Related]
18. Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study.
Gupta RK; Rosenheim J; Bell LC; Chandran A; Guerra-Assuncao JA; Pollara G; Whelan M; Artico J; Joy G; Kurdi H; Altmann DM; Boyton RJ; Maini MK; McKnight A; Lambourne J; Cutino-Moguel T; Manisty C; Treibel TA; Moon JC; Chain BM; Noursadeghi M;
Lancet Microbe; 2021 Oct; 2(10):e508-e517. PubMed ID: 34250515
[TBL] [Abstract][Full Text] [Related]
19. Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients.
Rouchka EC; Chariker JH; Alejandro B; Adcock RS; Singhal R; Ramirez J; Palmer KE; Lasnik AB; Carrico R; Arnold FW; Furmanek S; Zhang M; Wolf LA; Waigel S; Zacharias W; Bordon J; Chung D
Sci Rep; 2021 Aug; 11(1):15715. PubMed ID: 34344959
[TBL] [Abstract][Full Text] [Related]
20. Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air.
Ramasamy R
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
